FDA requests nearly $2.4B for fiscal 2009
02/01/2008
The U.S. Food and Drug Administration (FDA) is requesting nearly $2.4 billion “to protect and promote public health” as part of the President’s fiscal year 2009 (FY09) budget. This amount would be a 5.7 percent increase over the budget that FDA received for the current fiscal year. The FY09 request covers the period of Oct. 1, 2008 through Sept. 30, 2009.
The budget proposal includes strategic increases to strengthen food protection, modernize drug safety, speed approval of generic drugs, and improve the safety and review of medical devices. The request also includes funds to cover cost of living increases for FDA employees that perform the agency’s scientific and highly specialized public health mission.
“The FDA is committed to protecting and promoting the health of the American people,” says Andrew C. von Eschenbach, M.D., Commissioner of FDA. “This budget enables us to continue development of the staff and programs necessary to safeguard the food we eat and improve the safety and development of drugs, vaccines, devices, and other medical products.”
During FY09, FDA will experience a full-time equivalent staff increase of 526. The FY09 budget supports additional staff for priority areas such as food defense and food safety, as well as drug, blood, and human tissue safety programs. FDA will also work to ensure the safety of domestic and imported food and medical products by conducting more domestic and foreign inspections and more inspections of high-risk foods.
FDA’s key proposed budget increases support the following:
- Protecting America’s food supply ($42.2 million). FDA’s Protecting America’s Food Supply initiative integrates food safety and food defense and uses a comprehensive, preventative, and risk-based approach to safeguard the food supply and the American homeland (see “Food Safety Plan Emphasizes ‘Effective Action’ to Prevent Food Supply Contamination,” CleanRooms magazine, December 2007, p. 8).
The foundation of the plan is to increase its focus on prevention, to identify potential food threats to the food supply, and counteract them before they harm consumers. The FY09 increase will allow the agency to focus on the most important food defense and food safety issues throughout the entire life cycle of foods, from production through consumption. In FY 2009, FDA will devote more workforce and resources to food production and handling sites, whether they are located in the United States or abroad. - Medical product safety and development ($17.4 million, $79.0 million user fees). This initiative provides targeted resources to improve the safety of human and animal drugs, blood, human tissues, and medical devices. FDA says the resources will strengthen its ability to effectively monitor the safety of medical products, including imported products. The agency will also help medical product manufacturers develop new technologies to treat life-threatening diseases and conditions.
In 2007, Congress enacted the Food and Drug Administration Amendments Act (FDAAA). The FY09 budget implements new drug and medical device safety programs in FDAAA that are funded by user fees. As a result, FDA will strengthen its ability to regulate medical products and ensure their safety and effectiveness for the American public. - Management efficiencies. The FY09 budget also captures the productivity savings (???$8.9 million) generated by recent FDA investments and reinvests the savings in priority food safety and medical product programs.
For more information on the President’s FY09 budget for FDA, visit www.fda.gov.
Particles
compiled by Jason Andrukaitis
DSM and FDA join for innovative partnership
DSM Pharmaceuticals Inc. and the FDA have recently signed an agreement to collaborate on a project involving statistical quality by design methodology during pharmaceutical manufacturing. Dr. Barry Gujral of DSM and Dr. Maziar Kakhi of FDA will jointly work to build mathematical models using quality by design, statistical process control, design space, and risk analysis methodologies. The goal of this project is to recommend changes that support the pharmaceutical manufacturing sector’s focus on proactively managing manufacturing processes, enhancing efficiency, and improving quality.
Cleanroom developed for hermetic sealing
Litron, Inc.’s new cleanroom is designed to deliver hermetically sealed components virtually free of impurities, corrosive moisture, and damaging electrostatic discharge. Litron, a primary outsourcing partner for aerospace, now houses its glovebox units in a 3,000-square foot Class 100,000 cleanroom. This adds an important new level of protection for manufacturers providing electronics, fiber-optics, or microwave technology for cockpits, defense systems, and satellites and other critical components. Litron, Inc. has approval to provide services for NASA-related products and has a ten-year history of fabricating, laser welds, and laser-cut metal parts and components.
Particles
compiled by Jason Andrukaitis
Consulting firm mentors young professionals
R. Vijayakumar, PhD, has announced the formation of AERFIL, LLC, a new consulting services company offering services in aerosol science, filtration, and contamination control. AERFIL’s client focus will be small and medium-sized companies that need technical and industry expertise to compete effectively in the marketplace, but cannot afford full time resources. The firm will offer its clients opportunities to mentor young professionals on a non-profit basis.
B. Braun supplier recalls flush syringes
B. Braun Medical, Inc. was recently notified by its contract manufacturer, AM2PAT, Inc., of a nationwide recall of all lots and sizes of pre-filled heparin and saline flush syringes. An ongoing FDA inspection of AM2PAT, Inc.’s facility and a CDC investigation, has determined that there is a potential for the sterility of these affected products to be compromised. Customers that have the recalled product in their possession should discontinue use immediately.
Bosch opens new facility in India
Bosch Packaging Technology inaugurated its new state of the art manufacturing facility in Verna Industrial Estate (Goa/India) early in December. The new facility with 2,600 m2 produces and assembles packaging technology equipment for requirements such as candy wrapping, solid food, and biscuit packaging as well as packing vials, ampoules, and syringes. The Goa facility employs 80 associates and has an initial installed capacity of 120 machines a year with plans to increase this to 240 machines in three years.